Iberdomide (CC220)
Iberdomide (CC-220) is a novel oral immunomodulatory compound that targets cereblon, part of the CRL4CRBN E3 ubiquitin ligase complex, with an IC50 of 60 nM in a competitive TR-FRET assay. Iberdomide (CC-220) induces apoptosis with antitumor and immunostimulatory activities.
Supplier | Selleck Chemicals |
---|---|
Product # | S8760 |
Sku # | S8760-25mg |
Pricing | 25mg, $527.00 |
Citations for this product:
-
bioRxiv - Biochemistry 2024Quote: ... CC220 (Selleck Chemicals #S8760), CC122 (Selleck Chemicals #S7892) ...